C12N 2310/17
Immunomodulatory nucleic acids
C12N2310/17 (Immunomodulatory nucleic acids) appears on 425 US grants and 817 published applications in this corpus.
Search patents in C12N- Granted patents
- 425
- Published applications
- 817
- Assignees
- 321
- Inventors
- 1,068
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 4 | 0 |
| 2002 | 0 | 2 |
| 2003 | 2 | 9 |
| 2004 | 0 | 14 |
| 2005 | 0 | 29 |
| 2006 | 1 | 23 |
| 2007 | 4 | 11 |
| 2008 | 3 | 19 |
| 2009 | 7 | 28 |
| 2010 | 12 | 33 |
| 2011 | 19 | 38 |
| 2012 | 25 | 35 |
| 2013 | 19 | 25 |
| 2014 | 25 | 40 |
| 2015 | 32 | 47 |
| 2016 | 32 | 52 |
| 2017 | 25 | 41 |
| 2018 | 34 | 48 |
| 2019 | 38 | 44 |
| 2020 | 21 | 35 |
| 2021 | 22 | 49 |
| 2022 | 25 | 57 |
| 2023 | 20 | 46 |
| 2024 | 15 | 41 |
| 2025 | 24 | 30 |
| 2026 | 13 | 21 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- TLR9 agonists21 Jul 2026US 12,686,870 B2SBI Biotech Co., Ltd.
- RNA preparations comprising purified modified RNA for reprogramming cells16 Jun 2026US 12,655,395 B2
- MicroRNA as a therapeutic agent16 Jun 2026US 12,655,429 B2City of Hope
- Compositions and methods for inducing an enhanced immune response using poxvirus vectors2 Jun 2026US 12,644,125 B2Bavarian Nordic A/S
- CD40 specific DNA aptamers as vaccine adjuvants5 May 2026US 12,618,074 B2Board of Trustees of the University of Arkansas
- Rna preparations comprising purified modified rna for reprogramming cells1 Oct 2026US 2026/0297538 A1The Trustees of the University of Pennsylvania
- Conjugated antisense compounds and their use3 Sep 2026US 2026/0258417 A1Ionis Pharmaceuticals, Inc.
- Conjugated antisense compounds and their use27 Aug 2026US 2026/0250680 A1Ionis Pharmaceuticals, Inc.
- Short interspersed nuclear repeat element rna of imprinted micro-rna clusters mediate intrinsic type iii interferon-driven viral resistance20 Aug 2026US 2026/0240890 A1University of South Florida
- Compositions and methods for modulating ttr expression13 Aug 2026US 2026/0234624 A1Ionis Pharmaceuticals, Inc.
Most cited
By later US patents
- Immunostimulatory nucleic acid molecules472US 6,207,646 B1Coley Pharmaceutical Group, Inc. · 2001
- Immunostimulatory nucleic acid molecules461US 6,239,116 B1Coley Pharmaceutical Group, Inc. · 2001
- RNA containing modified nucleosides and methods of use thereof353US 8,278,036 B2The Trustees of the University of Pennsylvania · 2012
- Immunomodulatory oligonucleotides335US 6,194,388 B1Coley Pharmaceutical Group, Inc. · 2001
- RNA containing modified nucleosides and methods of use thereof230US 8,691,966 B2The Trustees of the University of Pennsylvania · 2014